The expression of the hormonal receptor in the CTC/CTM of breast cancer patients after clinical treatment might be variable during follow-up visits, suggesting the potential correlation of the expression of the hormonal receptor with clinical treatments. Here, NR4A1 is linked to breast carcinoma.